These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 31879125)

  • 21. Unmasking herd protection by an oral cholera vaccine in a cluster-randomized trial.
    Ali M; Qadri F; Kim DR; Islam T; Im J; Ahmmed F; Chon Y; Islam Khan A; Zaman K; Marks F; Clemens JD
    Int J Epidemiol; 2019 Aug; 48(4):1252-1261. PubMed ID: 30968110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral vaccines for preventing cholera.
    Sinclair D; Abba K; Zaman K; Qadri F; Graves PM
    Cochrane Database Syst Rev; 2011 Mar; 2011(3):CD008603. PubMed ID: 21412922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral Cholera Vaccination Delivery Cost in Low- and Middle-Income Countries: An Analysis Based on Systematic Review.
    Mogasale V; Ramani E; Wee H; Kim JH
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005124. PubMed ID: 27930668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety of the oral cholera vaccine in pregnancy: Retrospective findings from a subgroup following mass vaccination campaign in Dhaka, Bangladesh.
    Khan AI; Ali M; Chowdhury F; Saha A; Khan IA; Khan A; Akter A; Asaduzzaman M; Islam MT; Kabir A; You YA; Saha NC; Cravioto A; Clemens JD; Qadri F
    Vaccine; 2017 Mar; 35(11):1538-1543. PubMed ID: 28196715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The interplay between WASH practices and vaccination with oral cholera vaccines in protecting against cholera in urban Bangladesh: Reanalysis of a cluster-randomized trial.
    Chowdhury F; Aziz AB; Ahmmed F; Ahmed T; Kang SS; Im J; Park J; Tadesse BT; Islam MT; Kim DR; Hoque M; Pak G; Khanam F; McMillan NAJ; Liu X; Zaman K; Khan AI; Kim JH; Marks F; Qadri F; Clemens JD
    Vaccine; 2023 Mar; 41(14):2368-2375. PubMed ID: 36898931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First outbreak response using an oral cholera vaccine in Africa: vaccine coverage, acceptability and surveillance of adverse events, Guinea, 2012.
    Luquero FJ; Grout L; Ciglenecki I; Sakoba K; Traore B; Heile M; Dialo AA; Itama C; Serafini M; Legros D; Grais RF
    PLoS Negl Trop Dis; 2013; 7(10):e2465. PubMed ID: 24147164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Willingness to pay for oral cholera vaccines in urban Bangladesh.
    Sarker AR; Islam Z; Sultana M; Sheikh N; Mahumud RA; Islam MT; Meer RV; Morton A; Khan AI; Clemens JD; Qadri F; Khan JAM
    PLoS One; 2020; 15(4):e0232600. PubMed ID: 32353086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of two doses of Euvichol-plus oral cholera vaccine in response to the 2017/2018 outbreak: a matched case-control study in Lusaka, Zambia.
    Sialubanje C; Kapina M; Chewe O; Matapo BB; Ngomah AM; Gianetti B; Ngosa W; Kasonde M; Musonda K; Mulenga M; Michelo C; Sinyange N; Bobo P; Zyambo K; Mazyanga L; Bakyaita N; Mukonka VM
    BMJ Open; 2022 Nov; 12(11):e066945. PubMed ID: 36368745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of the Euvichol® oral cholera vaccine at 2 years: A case-control and bias-indicator study in Haiti.
    Matias WR; Guillaume Y; Cene Augustin G; Vissieres K; Ternier R; Slater DM; Harris JB; Franke MF; Ivers LC
    Int J Infect Dis; 2024 Feb; 139():153-158. PubMed ID: 38000510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral cholera vaccination coverage in an acute emergency setting in Somalia, 2017.
    Lubogo M; Mohamed AM; Ali AH; Ali AH; Popal GR; Kiongo D; Bile KM; Malik M; Abubakar A
    Vaccine; 2020 Feb; 38 Suppl 1():A141-A147. PubMed ID: 31980193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Costs of illness due to cholera, costs of immunization and cost-effectiveness of an oral cholera mass vaccination campaign in Zanzibar.
    Schaetti C; Weiss MG; Ali SM; Chaignat CL; Khatib AM; Reyburn R; Duintjer Tebbens RJ; Hutubessy R
    PLoS Negl Trop Dis; 2012; 6(10):e1844. PubMed ID: 23056660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Impact of a One-Dose versus Two-Dose Oral Cholera Vaccine Regimen in Outbreak Settings: A Modeling Study.
    Azman AS; Luquero FJ; Ciglenecki I; Grais RF; Sack DA; Lessler J
    PLoS Med; 2015 Aug; 12(8):e1001867. PubMed ID: 26305226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global economic evaluation of oral cholera vaccine: A systematic review.
    Teoh SL; Kotirum S; Hutubessy RCW; Chaiyakunapruk N
    Hum Vaccin Immunother; 2018 Feb; 14(2):420-429. PubMed ID: 29099647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neighborhood-targeted and case-triggered use of a single dose of oral cholera vaccine in an urban setting: Feasibility and vaccine coverage.
    Parker LA; Rumunu J; Jamet C; Kenyi Y; Lino RL; Wamala JF; Mpairwe AM; Muller V; Llosa AE; Uzzeni F; Luquero FJ; Ciglenecki I; Azman AS
    PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005652. PubMed ID: 28594891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral cholera vaccine coverage during a preventive door-to-door mass vaccination campaign in Nampula, Mozambique.
    Semá Baltazar C; Rafael F; Langa JPM; Chicumbe S; Cavailler P; Gessner BD; Pezzoli L; Barata A; Zaina D; Inguane DL; Mengel MA; Munier A
    PLoS One; 2018; 13(10):e0198592. PubMed ID: 30281604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lessons learnt from 12 oral cholera vaccine campaigns in resource-poor settings.
    Hsiao A; Desai SN; Mogasale V; Excler JL; Digilio L
    Bull World Health Organ; 2017 Apr; 95(4):303-312. PubMed ID: 28479625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral cholera vaccination strategy: Self-administration of the second dose in urban Dhaka, Bangladesh.
    Khan AI; Islam MS; Islam MT; Ahmed A; Chowdhury MI; Chowdhury F; Siddik MAU; Clemens JD; Qadri F
    Vaccine; 2019 Feb; 37(6):827-832. PubMed ID: 30639459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A reactive vaccination campaign with single dose oral cholera vaccine (OCV) during a cholera outbreak in Cameroon.
    Amani A; Tatang CA; Bayiha CN; Woung M; Ngo Bama S; Nangmo A; Mbang MA; Epee Douba E
    Vaccine; 2021 Feb; 39(8):1290-1296. PubMed ID: 33494966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High cholera vaccination coverage following emergency campaign in Haiti: Results from a cluster survey in three rural Communes in the South Department, 2017.
    Sharp A; Blake A; Backx J; Panunzi I; Barrais R; Nackers F; Luquero F; Deslouches YG; Cohuet S
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007967. PubMed ID: 32004316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of Hillchol®, a low-cost inactivated single strain Hikojima oral cholera vaccine.
    Sharma T; Joshi N; Kumar Mandyal A; Nordqvist SL; Lebens M; Kanchan V; Löfstrand M; Jeverstam F; Mainul Ahasan M; Khan I; Karim M; Muktadir H; Muktadir A; Gill D; Holmgren J
    Vaccine; 2020 Nov; 38(50):7998-8009. PubMed ID: 33139137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.